Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Uroplakin 1B (Upk1b) stabilizes epithelial cells lining the bladder lumen to prevent rupturing during bladder distension. Little is known about Upk1b expression in other normal and malignant tissues. To comprehensively evaluate the potential diagnostic and prognostic utility of Upk1b expression analysis, a tissue microarray containing 14,061 samples from 127 different tumor types and subtypes and 608 samples of 76 different normal tissue types was analyzed by immunohistochemistry. Upk1b immunostaining was found in 61 (48%) different tumor types including 50 (39%) with at least one moderately positive and 39 tumor types (31%) with at least one strongly positive tumor. Highest positivity rates were found in urothelial neoplasms (58-95%), Brenner tumors of the ovary (92%), epithelioid mesothelioma (87%), serous carcinoma of the ovary (58%) and the endometrium (53%) as well as in squamous cell carcinoma of the head and neck (18-37%), lung (39%), and esophagus (26%). In urothelial carcinoma, low Upk1b expression was linked to high grade and invasive tumor growth (P < .0001 each) and nodal metastasis (P = .0006). Our data suggest diagnostic applications of Upk1b immunohistochemistry in panels for the distinction of malignant mesothelioma from adenocarcinoma of the lung, urothelial carcinoma from prostatic adenocarcinoma in the bladder, or pancreaticobiliary and gastroesophageal from colorectal adenocarcinoma.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.humpath.2022.05.002 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The role of UPK1B in gastric cancer: multi-omics analysis and experimental validation.
Discov Oncol
April 2025
Department of General Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, 230022, Anhui Province, People's Republic of China.
Background: UPK1B has been implicated in various cancers; however, its mechanism of action in gastric cancer remains elusive.
Methods: We utilized transcriptional data and clinical information, and mutation profiles from The Cancer Genome Atlas (TCGA) database to analyze UPK1B's expression and clinical relevance. Biological enrichment, immune microenvironment characterization, and drug sensitivity analyses were conducted.
Identification of Fatty Acid Metabolism-Related Subtypes in Gastric Cancer Aided by Machine Learning.
Cancer Manag Res
October 2024
Department of Oncology, Jining, 272000, People's Republic of China.
Article Synopsis
- Gastric cancer is a significant health issue worldwide, and this study explores the impact of fatty acid metabolism on the disease to improve clinical decisions by analyzing gene subtypes through public databases and machine learning.
- The researchers identified 71 differentially expressed genes (DEGs) related to fatty acid metabolism, creating two gene subtypes (C1 and C2) and found notable differences in immune responses between them.
- A prognostic model was developed based on these gene subtypes, allowing for classification of patients into high-risk and low-risk groups; this model can aid clinicians in evaluating patient prognosis and making informed treatment decisions.
Article Synopsis
- - A study aimed to identify biomarkers related to NAD+ metabolism in gastric cancer (GC) to improve prognosis and treatment approaches for patients.
- - Researchers compared gene expressions in GC tissues versus normal tissues, identifying seven key NAD+ metabolism-related genes that could predict patient outcomes based on their expression levels.
- - Analysis suggested that these biomarkers are linked to immune cell activity and specific biological pathways, providing valuable insights for future cancer therapies.
Over-expression of KRT17 and MDK genes at mRNA levels in urine-exfoliated cells is associated with early non-invasive diagnosis of non-muscle-invasive bladder cancer.
Clin Biochem
October 2024
Department of Clinical Biochemistry, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran. Electronic address:
Introduction: Current diagnostic approaches for bladder cancer (BLCA) are often invasive or lack the required sensitivity and specificity. This underscores the need for an early non-invasive diagnostic test for BLCA. This work aimed to explore the potential of molecular markers in urine-exfoliated cells for the diagnosis of non-muscle-invasive bladder cancer (NMIBC).
View Article and Find Full Text PDFGene of the month: the uroplakins.
J Clin Pathol
April 2024
School of Medicine and Population Health, The University of Sheffield, Sheffield, UK.
Article Synopsis
- * There are four types of uroplakin proteins in humans, which are found on the outer membrane of bladder cells known as umbrella cells, where they form protective structures called urothelial plaques.
- * Uroplakins not only have a role in maintaining the bladder's barrier function but are also important in kidney development and can be used as markers for diagnosing urothelial cancers due to their specific expression in cancer cells.